These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35320883)

  • 41. Cytoreductive surgery combined with organ resection for advanced ovarian carcinoma.
    Todo Y; Sakuragi N; Oikawa M; Negishi H; Yamamoto R; Yoshiaki K; Tsumura N; Kawaguchi I; Fujimoto S
    Int J Clin Oncol; 2003 Apr; 8(2):90-6. PubMed ID: 12720101
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative study of three different managements after colorectal anastomosis in ovarian cancer: conservative management, diverting ileostomy, and ghost ileostomy.
    Lago V; Sanchez-Migallón A; Flor B; Padilla-Iserte P; Matute L; García-Granero Á; Bustamante M; Domingo S
    Int J Gynecol Cancer; 2019 Sep; 29(7):1170-1176. PubMed ID: 31296558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical observation of partial pancreatectomy as part of primary cytoreductive surgery in advanced epithelial ovarian cancer].
    Xiang LB; Tu YX; He TC; Pei X; Shen XX; Yang WT; Wu XH; Yang HJ
    Zhonghua Fu Chan Ke Za Zhi; 2016 May; 51(5):361-5. PubMed ID: 27256444
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Urinary complications of pelvic exenterations for rectal cancer with urinary invasion].
    Gas J; Beauval JB; Chalret du Rieu M; Bou Nasr E; Philis A; Kirzin S; Thoulouzan M; Soulié M; Ghouti L
    Prog Urol; 2015 May; 25(6):348-54. PubMed ID: 25804429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transitory Stoma at the Time of Complete Cytoreductive Surgery Affects Survival for Patients with Advanced-stage Ovarian Cancer.
    Canlorbe G; Touboul C; Chargari C; Bentivegna E; Maulard A; Pautier P; Genestie C; Morice P; Gouy S
    Anticancer Res; 2018 Mar; 38(3):1517-1523. PubMed ID: 29491080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
    Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Morbidity of rectosigmoid resection in cytoreductive surgery for ovarian cancer. Risk factor analysis.
    Fournier M; Huchon C; Ngo C; Bensaid C; Bats AS; Combe P; le FrèreBelda MA; Fournier L; Berger A; Lecuru F
    Eur J Surg Oncol; 2018 Jun; 44(6):750-753. PubMed ID: 29580734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
    Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
    Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Primary cytoreductive surgery of advanced ovarian cancer with special reference to the significance of bowel resection].
    Sato K; Horiguchi M; Kimura M; So E; Kojima T; Tamuna M; Shima Y; Numaguchi M; Uno K; Maru H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1070-7. PubMed ID: 2730012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities.
    Fotopoulou C; Jones BP; Savvatis K; Campbell J; Kyrgiou M; Farthing A; Brett S; Roux R; Hall M; Rustin G; Gabra H; Jiao L; Stümpfle R
    Arch Gynecol Obstet; 2016 Sep; 294(3):607-14. PubMed ID: 27040418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON.
    Cianci S; Fedele C; Vizzielli G; Pasciuto T; Gueli Alletti S; Cosentino F; Chiantera V; Fagotti A; Scambia G
    Gynecol Oncol; 2022 Feb; 164(2):271-277. PubMed ID: 34844774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low anterior resection syndrome (LARS) in ovarian cancer patients - A multi-centre comparative cohort study.
    Harpain F; Kranawetter M; Zott T; Lazaridis II; Guenin MO; Ninkovic M; Kronberger IE; Tapiolas I; Basany EE; Dauser B; Herbst F; Koh C; Stift A; Teleky B; Reinthaller A; Grimm C; Riss S
    Int J Surg; 2020 Jun; 78():97-102. PubMed ID: 32304899
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy.
    Maheshwari A; Kumar N; Gupta S; Rekhi B; Shylasree TS; Dusane R; Bajpai J; Ghosh J; Gulia S; Deodhar K; Menon S; Popat P; Sable N; Thakur M; Kerkar R
    Indian J Cancer; 2018; 55(1):50-54. PubMed ID: 30147093
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer.
    Coleridge SL; Bryant A; Kehoe S; Morrison J
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD005343. PubMed ID: 33543776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of immediate surgical outcomes between posterior pelvic exenteration and standard resection for primary rectal cancer: a matched case-control study.
    Lohsiriwat V; Lohsiriwat D
    World J Gastroenterol; 2008 Apr; 14(15):2414-7. PubMed ID: 18416472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of residual disease at interval debulking surgery on platinum resistance and patterns of recurrence for advanced-stage ovarian cancer.
    Greer A; Gockley A; Manning-Geist B; Melamed A; Sisodia RC; Berkowitz R; Horowitz N; Del Carmen M; Growdon WB; Worley M
    Int J Gynecol Cancer; 2021 Oct; 31(10):1341-1347. PubMed ID: 34429355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall.
    Nishikimi K; Tate S; Matsuoka A; Shozu M
    Int J Clin Oncol; 2019 Aug; 24(8):941-949. PubMed ID: 30891652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of morbidity associated with pancreatic resection during cytoreductive surgery for epithelial ovarian cancer: A systematic review.
    Di Donato V; Bardhi E; Tramontano L; Capomacchia FM; Palaia I; Perniola G; Plotti F; Angioli R; Giancotti A; Muzii L; Panici PB
    Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):694-702. PubMed ID: 31806515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.